News
Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated ...
MIRA is advancing complementary non-opioid therapies for two of the largest pain markets MIAMI, FLORIDA / ACCESS Newswire / ...
The keen interest from Big Pharma has also excited the stock market. After the Otsuka deal was announced, HBM's share price ...
Opinion: Legal scholar John Shu says a ban or restriction on direct-to-consumer drug advertisements would be illogical and ...
Proponents say direct-to-consumer sales by drugmakers cut out intermediaries that add needlessly to prices. Detractors see ethical issues and prices that are still too high for many patients.
As critics of the pharmaceutical industry have begun floating the idea of banning direct-to-consumer (DTC) pharmaceutical ...
A legislative ban on pharma ads, a tool for companies to amplify messaging on drugs, including for precision medicines, is ...
Hiking in a slot canyon wearing a plaid flannel shirt is a symptom of having moderate to severe rheumatoid arthritis.
Novo Nordisk has terminated its partnership with telehealth company Hims & Hers Health, accusing it of deceptively marketing ...
The U.S. is rare among Western nations because it allows pharmaceutical advertising. But a new effort aims to stop it. A bill was introduced in Congress recently that would ban pharmaceutical ...
Drugmaker Novo Nordisk said it is halting its agreement with telehealth company Hims & Hers after less than two months, ...
The drug, called Yeztugo from company Gilead Sciences, was approved Wednesday based on data from clinical trials that showed 99.9% of participants who received it remained HIV negative.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results